JLE

Médecine thérapeutique / Pédiatrie

MENU

Vaccination des garçons contre le papillomavirus Volume 19, issue 4, Octobre-Novembre-Décembre 2016

Figures


  • Figure 1
Author
Hôpitaux pédiatriques CHU Lenval,
Urgences Pédiatriques – Infectiologie,
57 avenue de la Californie,
06200 Nice
* Tirés à part

The involvement of certain human papillomaviruses (HPV) is well known in the genesis of cervical cancer, but also in other cancers of women and those affecting also men. The question of the relevance of a generalized or targeted vaccination of men against HPV has been discussed. The High Council for Public Health (HCSP) recently published an opinion on targeted vaccine recommendations for men, including men who have sex with men (MSM). However, a generalized HPV vaccination established before adolescence could protect individuals of both sexes before they began their sexuality. The strategy of vaccinating only MSM is faced with the problem of the feasibility of vaccinating before the manifestation of sexual preference and therefore of exposure to risk. It is coherent in terms of equality and responsibility to involve both sexes in this prevention of a sexually transmitted infection. It is also necessary to take into account the expected improvement in the implementation of vaccination due to mixed programs and the impact on the very common benign cancers and benign tumors associated with HPV affecting both sexes.